Alopexx Vaccine

100 Main Street
Suite 110
Concord
Massachusetts
01742
United States

Show jobs for this employer

About Alopexx Vaccine

Alopexx Vaccine, LLC is developing a vaccine against a proprietary antigenic target - dPNAG.

YEAR FOUNDED: 2006

LEADERSHIP:

Founders: Daniel R. Vlock, Deborah Ramsdell and Christine de los Reyes

Founder and CEO: Daniel R. Vlock

CLINICAL TRIAL:

Please click here for clinical trial information.

4 articles about Alopexx Vaccine